In addition to the duties described in ORS 414.361, the Pharmacy and Therapeutics Committee shall do the following subject to the approval of the Director of the Oregon Health Authority: (1) Publish an annual report, as described in ORS 414.382. (2) Publish and disseminate educational information to prescribers and pharmacists regarding the committee and the drug use review programs, including information on the following: (a) Identifying and reducing the frequency of patterns of fraud, abuse or inappropriate or medically unnecessary care among prescribers, pharmacists and recipients. (b) Potential or actual severe or adverse reactions to drugs. (c) Therapeutic appropriateness. (d) Overutilization or underutilization. (e) Appropriate use of generic products. (f) Therapeutic duplication. (g) Drug-disease contraindications. (h) Drug-drug interactions. (i) Drug allergy interactions. (j) Clinical abuse and misuse. (3) Adopt and implement procedures designed to ensure the confidentiality of any information that identifies individual prescribers, pharmacists or recipients and that is collected, stored, retrieved, assessed or analyzed by the committee, staff of the committee, the Oregon Health Authority or contractors to the committee or the authority. Note: See note under 414.351.
‹ Prev All Oregon sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.